0001929354-23-000009.txt : 20230522
0001929354-23-000009.hdr.sgml : 20230522
20230522163001
ACCESSION NUMBER: 0001929354-23-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230518
FILED AS OF DATE: 20230522
DATE AS OF CHANGE: 20230522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Caissa Capital Management ltd.
CENTRAL INDEX KEY: 0001929354
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 23944873
BUSINESS ADDRESS:
STREET 1: PALM GROVE HOUSE
STREET 2: WICKHAMS CAY 1 ROAD TOWN
CITY: TORTOLA
STATE: D8
ZIP: VG1110
BUSINESS PHONE: 00377 99 90 25 95
MAIL ADDRESS:
STREET 1: PALM GROVE HOUSE
STREET 2: WICKHAMS CAY 1 ROAD TOWN
CITY: TORTOLA
STATE: D8
ZIP: VG1110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0407
4
2023-05-18
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0001929354
Caissa Capital Management ltd.
PALM GROVE HOUSE
WICKHAMS CAY 1 ROAD TOWN
TORTOLA
D8
VG1110
VIRGIN ISLANDS, BRITISH
0
0
1
0
0
Common stock
2023-05-18
4
P
0
13121
3.2896
A
1360200
I
See Footnote (1)
Common stock
2023-05-19
4
P
0
6500
3.5157
A
1366700
I
See Footnote (1)
Common stock
2023-05-22
4
P
0
7000
3.3368
A
1373700
I
See Footnote (1)
Common stock
182300
D
Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.80 to $3.40, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.4 to $3.6, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00 to $3.72, inclusive.
These share are directly owned by Mr. Golestaneh in his personal capacity.
Cambyz Golestaneh, Title: Director
2023-05-22